rs201519600
Positions:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The ENST00000338702.4(MAOA):āc.137A>Gā(p.Asp46Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000168 in 1,206,525 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 65 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Genomes: š 0.000054 ( 0 hom., 2 hem., cov: 22)
Exomes š: 0.00018 ( 0 hom. 63 hem. )
Consequence
MAOA
ENST00000338702.4 missense
ENST00000338702.4 missense
Scores
9
5
3
Clinical Significance
Conservation
PhyloP100: 5.16
Genes affected
MAOA (HGNC:6833): (monoamine oxidase A) This gene is one of two neighboring gene family members that encode mitochondrial enzymes which catalyze the oxidative deamination of amines, such as dopamine, norepinephrine, and serotonin. Mutation of this gene results in Brunner syndrome. This gene has also been associated with a variety of other psychiatric disorders, including antisocial behavior. Alternatively spliced transcript variants encoding multiple isoforms have been observed. [provided by RefSeq, Jul 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.864
BS2
High Hemizygotes in GnomAd4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAOA | NM_000240.4 | c.137A>G | p.Asp46Gly | missense_variant | 2/15 | ENST00000338702.4 | NP_000231.1 | |
MAOA | NM_001270458.2 | c.-263A>G | 5_prime_UTR_variant | 3/16 | NP_001257387.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAOA | ENST00000338702.4 | c.137A>G | p.Asp46Gly | missense_variant | 2/15 | 1 | NM_000240.4 | ENSP00000340684 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000537 AC: 6AN: 111680Hom.: 0 Cov.: 22 AF XY: 0.0000591 AC XY: 2AN XY: 33844
GnomAD3 genomes
AF:
AC:
6
AN:
111680
Hom.:
Cov.:
22
AF XY:
AC XY:
2
AN XY:
33844
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000491 AC: 9AN: 183292Hom.: 0 AF XY: 0.0000590 AC XY: 4AN XY: 67814
GnomAD3 exomes
AF:
AC:
9
AN:
183292
Hom.:
AF XY:
AC XY:
4
AN XY:
67814
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000180 AC: 197AN: 1094845Hom.: 0 Cov.: 28 AF XY: 0.000175 AC XY: 63AN XY: 360291
GnomAD4 exome
AF:
AC:
197
AN:
1094845
Hom.:
Cov.:
28
AF XY:
AC XY:
63
AN XY:
360291
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000537 AC: 6AN: 111680Hom.: 0 Cov.: 22 AF XY: 0.0000591 AC XY: 2AN XY: 33844
GnomAD4 genome
AF:
AC:
6
AN:
111680
Hom.:
Cov.:
22
AF XY:
AC XY:
2
AN XY:
33844
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
3
ExAC
AF:
AC:
6
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 08, 2014 | The c.137A>G (p.D46G) alteration is located in exon 2 (coding exon 2) of the MAOA gene. This alteration results from a A to G substitution at nucleotide position 137, causing the aspartic acid (D) at amino acid position 46 to be replaced by a glycine (G). The heterozygous missense change is ultra rare in healthy individuals:_x000D_ Based on data from the NHLBI Exome Sequencing Project (ESP), the MAOA c.137A>G alteration was not observed among 6,503 individuals tested. Allele frequency data for this nucleotide position are not currently available from the 1000 Genomes Project. This variant is reported in the SNPDatabase as rs201519600. The altered amino acid is conserved throughout evolution:_x000D_ The p.D46 amino acid is well conserved in available vertebrate species. The amino acid is located in a functionally important protein domain:_x000D_ The p.D46G amino acid is located within the FAD-binding domain of the MAOA protein (Colibus, 2005). In silico prediction is conflicting:_x000D_ The p.D46G alteration is predicted to be possibly damaging by Polyphen and tolerated by SIFT in silico analyses. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 31, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Pathogenic
D
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Benign
D
Sift4G
Uncertain
D
Polyphen
P
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at